Clinical Trial Update: Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for a second-line treatment in patients with platinum-sensitive ovarian cancer. Sponsored by Duke University,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Duke University | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-02-04